Principal Financial Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,167
| Closed | -$291K | – | 2395 |
|
|
2024
Q2 | $291K | Sell |
14,167
-4,662
| -25% | -$95.7K | ﹤0.01% | 2063 |
|
|
2024
Q1 | $448K | Sell |
18,829
-36,365
| -66% | -$865K | ﹤0.01% | 2011 |
|
|
2023
Q4 | $1.19M | Buy |
55,194
+12,074
| +28% | +$261K | ﹤0.01% | 1820 |
|
|
2023
Q3 | $626K | Buy |
43,120
+9,371
| +28% | +$136K | ﹤0.01% | 1911 |
|
|
2023
Q2 | $706K | Buy |
33,749
+6,014
| +22% | +$126K | ﹤0.01% | 1890 |
|
|
2023
Q1 | $586K | Buy |
27,735
+417
| +2% | +$8.81K | ﹤0.01% | 1938 |
|
|
2022
Q4 | $695K | Buy |
27,318
+15,280
| +127% | +$389K | ﹤0.01% | 1910 |
|
|
2022
Q3 | $289K | Buy |
+12,038
| New | +$289K | ﹤0.01% | 2092 |
|
|
2021
Q3 | – | Sell |
-10,893
| Closed | -$187K | – | 2618 |
|
|
2021
Q2 | $187K | Buy |
+10,893
| New | +$187K | ﹤0.01% | 2484 |
|